S&P 500   3,836.84 (-0.12%)
DOW   30,858.07 (-0.45%)
QQQ   325.34 (-0.02%)
AAPL   141.50 (+1.75%)
MSFT   226.58 (+0.28%)
FB   275.30 (+0.29%)
GOOGL   1,870.66 (-1.16%)
AMZN   3,289.50 (-0.08%)
TSLA   865.13 (+2.18%)
NVDA   538.00 (-1.91%)
BABA   259.79 (+0.45%)
CGC   32.57 (-3.64%)
GE   10.90 (-1.89%)
MU   80.03 (-2.73%)
AMD   93.12 (+0.36%)
NIO   59.90 (-3.31%)
T   28.84 (-0.31%)
F   11.04 (-4.17%)
ACB   10.17 (-4.51%)
BA   200.97 (-2.37%)
DIS   170.67 (-1.22%)
NFLX   555.03 (-1.79%)
GILD   66.92 (-0.03%)
S&P 500   3,836.84 (-0.12%)
DOW   30,858.07 (-0.45%)
QQQ   325.34 (-0.02%)
AAPL   141.50 (+1.75%)
MSFT   226.58 (+0.28%)
FB   275.30 (+0.29%)
GOOGL   1,870.66 (-1.16%)
AMZN   3,289.50 (-0.08%)
TSLA   865.13 (+2.18%)
NVDA   538.00 (-1.91%)
BABA   259.79 (+0.45%)
CGC   32.57 (-3.64%)
GE   10.90 (-1.89%)
MU   80.03 (-2.73%)
AMD   93.12 (+0.36%)
NIO   59.90 (-3.31%)
T   28.84 (-0.31%)
F   11.04 (-4.17%)
ACB   10.17 (-4.51%)
BA   200.97 (-2.37%)
DIS   170.67 (-1.22%)
NFLX   555.03 (-1.79%)
GILD   66.92 (-0.03%)
S&P 500   3,836.84 (-0.12%)
DOW   30,858.07 (-0.45%)
QQQ   325.34 (-0.02%)
AAPL   141.50 (+1.75%)
MSFT   226.58 (+0.28%)
FB   275.30 (+0.29%)
GOOGL   1,870.66 (-1.16%)
AMZN   3,289.50 (-0.08%)
TSLA   865.13 (+2.18%)
NVDA   538.00 (-1.91%)
BABA   259.79 (+0.45%)
CGC   32.57 (-3.64%)
GE   10.90 (-1.89%)
MU   80.03 (-2.73%)
AMD   93.12 (+0.36%)
NIO   59.90 (-3.31%)
T   28.84 (-0.31%)
F   11.04 (-4.17%)
ACB   10.17 (-4.51%)
BA   200.97 (-2.37%)
DIS   170.67 (-1.22%)
NFLX   555.03 (-1.79%)
GILD   66.92 (-0.03%)
S&P 500   3,836.84 (-0.12%)
DOW   30,858.07 (-0.45%)
QQQ   325.34 (-0.02%)
AAPL   141.50 (+1.75%)
MSFT   226.58 (+0.28%)
FB   275.30 (+0.29%)
GOOGL   1,870.66 (-1.16%)
AMZN   3,289.50 (-0.08%)
TSLA   865.13 (+2.18%)
NVDA   538.00 (-1.91%)
BABA   259.79 (+0.45%)
CGC   32.57 (-3.64%)
GE   10.90 (-1.89%)
MU   80.03 (-2.73%)
AMD   93.12 (+0.36%)
NIO   59.90 (-3.31%)
T   28.84 (-0.31%)
F   11.04 (-4.17%)
ACB   10.17 (-4.51%)
BA   200.97 (-2.37%)
DIS   170.67 (-1.22%)
NFLX   555.03 (-1.79%)
GILD   66.92 (-0.03%)
Log in
ETR:SRT

Sartorius Aktiengesellschaft (SRT.F) Stock Forecast, Price & News

€343.00
+6.00 (+1.78 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
€337.00
Now: €343.00
€345.00
50-Day Range
€329.00
MA: €341.86
€350.00
52-Week Range
€145.00
Now: €343.00
€384.00
Volume2,423 shs
Average VolumeN/A
Market Capitalization$11.73 billion
P/E Ratio149.65
Dividend Yield0.10%
BetaN/A
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers live cell analysis system, and cell analysis reagents and consumables; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, cannabis testing, food and beverage, environmental, and paint mixing industries. Sartorius Aktiengesellschaft and Evotec SE has a partnership with Curexsys GmbH on iPSC-based therapeutic exosome approach. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Sartorius Aktiengesellschaft (SRT.F) logo

MarketRank

Overall MarketRank

0.57 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone49 551 308 0
Employees10,008
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.15 billion
Cash Flow€7.52 per share
Book Value€11.85 per share

Profitability

Miscellaneous

Market Cap$11.73 billion
Next Earnings Date1/27/2021 (Estimated)
OptionableOptionable
€343.00
+6.00 (+1.78 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SRT News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sartorius Aktiengesellschaft (SRT.F) (ETR:SRT) Frequently Asked Questions

How has Sartorius Aktiengesellschaft (SRT.F)'s stock price been impacted by COVID-19 (Coronavirus)?

Sartorius Aktiengesellschaft (SRT.F)'s stock was trading at €182.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SRT shares have increased by 88.5% and is now trading at €343.00.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Sartorius Aktiengesellschaft (SRT.F)?

Wall Street analysts have given Sartorius Aktiengesellschaft (SRT.F) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sartorius Aktiengesellschaft (SRT.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Sartorius Aktiengesellschaft (SRT.F)'s next earnings date?

Sartorius Aktiengesellschaft (SRT.F) is scheduled to release its next quarterly earnings announcement on Wednesday, January 27th 2021.
View our earnings forecast for Sartorius Aktiengesellschaft (SRT.F)
.

Is Sartorius Aktiengesellschaft (SRT.F) a good dividend stock?

Sartorius Aktiengesellschaft (SRT.F) pays an annual dividend of €0.35 per share and currently has a dividend yield of 0.10%. The dividend payout ratio of Sartorius Aktiengesellschaft (SRT.F) is 15.27%. This payout ratio is at a healthy, sustainable level, below 75%.
View Sartorius Aktiengesellschaft (SRT.F)'s dividend history.

Who are some of Sartorius Aktiengesellschaft (SRT.F)'s key competitors?

What other stocks do shareholders of Sartorius Aktiengesellschaft (SRT.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Aktiengesellschaft (SRT.F) investors own include American Eagle Outfitters (AEO), Align Technology (ALGN), Gilead Sciences (GILD), Agilent Technologies (A), ACADIA Pharmaceuticals (ACAD), Allianz SE (ALV.F) (ALV), AxoGen (AXGN), Biohaven Pharmaceutical (BHVN), Blueprint Medicines (BPMC) and Cerner (CERN).

Who are Sartorius Aktiengesellschaft (SRT.F)'s key executives?

Sartorius Aktiengesellschaft (SRT.F)'s management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 56, Pay $1.62M)
  • Mr. Rainer Lehmann, CFO, Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 45, Pay $710k)
  • Mr. John Gerard Mackay, Head of Lab Products & Services Division and Member of Exec. Board (Age 59, Pay $779k)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 46, Pay $649k)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 52, Pay $56k)
  • Mr. Manfred Werner, Sr. VP of Admin. Organization & Auditing
  • Ms. Mei Wang, Head of Production - China
  • Ms. Patricia Spannagel, Head of Quality Assurance - Mechatronics Division Goettingen
  • Mr. Rashid Maqbool, Head of Production & Certification Department - Denver USA
  • Mr. Manohar Kuppusami, Head of Production Department - India

What is Sartorius Aktiengesellschaft (SRT.F)'s stock symbol?

Sartorius Aktiengesellschaft (SRT.F) trades on the ETR under the ticker symbol "SRT."

What is Sartorius Aktiengesellschaft (SRT.F)'s stock price today?

One share of SRT stock can currently be purchased for approximately €343.00.

How big of a company is Sartorius Aktiengesellschaft (SRT.F)?

Sartorius Aktiengesellschaft (SRT.F) has a market capitalization of $11.73 billion and generates $2.15 billion in revenue each year. Sartorius Aktiengesellschaft (SRT.F) employs 10,008 workers across the globe.

What is Sartorius Aktiengesellschaft (SRT.F)'s official website?

The official website for Sartorius Aktiengesellschaft (SRT.F) is www.sartorius.com.

How can I contact Sartorius Aktiengesellschaft (SRT.F)?

The company can be reached via phone at 49 551 308 0.

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.